Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Finasteride helps hair growth but may cause sexual side effects and depression.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Two types of 5α-reductase are in dog skin, which might make dutasteride better than finasteride for treating dog hair loss.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Dutasteride helps reduce heavy drinking, especially for those who drink to cope.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Dutasteride and finasteride cause kidney damage, with dutasteride being more harmful.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Dutasteride is more effective than finasteride for long-term hair growth in men with androgenic alopecia.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

The document concludes that more research is needed on treatments for hair loss in both men and women, especially on medication combinations and their benefits.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Use antiandrogens and other treatments for hair loss.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

Finasteride may cause depression and suicidal thoughts, especially in young men.